Cervical cancer technology company Truscreen Group Limited (ASX/NZX: TRU) (the Company) has released its preliminary unaudited financial results for the year ended 31 March 2024

Related Keywords

Mexico , Hanoi , Han I , Vietnam , Republic Of , Saudi Arabia , Tanzania , Masvingo , Zimbabwe , Uzbekistan , New Zealand , Jakarta , Jakarta Raya , Indonesia , Macedonia , Masvingo Province , Poland , Kenya , China , Ghana , Uganda , Nigeria , Chinese , Martin Dillion , Phillips Pharma , Gynecology Association , Dr Sulaiman Al Habib Medical Group , Yahoo , Truscreen Group Limited , Artificial Intelligence Technology , Hotmail , Ministry Of Health , Gynecologic Department , International Federation Of Cervical Pathology , Vietnamese Ministry , European Union , Uzbekistan National Screening Solution For Cervical Cancer , National Aids Council , Vietnamese Ministry Of Health Approved Technical List , Child Institute , World Health Organisation , Chinese Society For Colposcopy , Phillips Pharma Group , New Zealand Dollars , Blue Paper , Chinese Society , Cervical Pathology , Vietnam Truscreen , Vietnamese Ministry Of Health , Chief Executive , Improved Operations , Key Performance , China Blue Paper , Cancer Three Stage Standardized Prevent , Intelligence Technology For Cervical Cancer , International Federation , Single Use Sensor , Child Care , Sulaiman Al Habib Medical Group , Middle Eastern , Health Approved Technical , Key Opinion Leaders , Hanoi Obstetrics , Uzbekistan National Screening Solution , Central Asian , Liquid Based Cytology , North Macedonia Truscreen , Pap Smear , Medical Device Regulation , Medical Device Directive , Truscreen Ultra ,